Alirocumab and chest pain after acute coronary syndrome: An analysis of ODYSSEY OUTCOMES

• Main Authors: Gregory P. Geba (Author), Ruifeng Chen (Author), Kasturi Talapatra (Author), Taylor Brackin (Author), Kusha A. Mohammadi (Author), Robert Pordy (Author), Garen Manvelian (Author), David J. Maron (Author), Gregory G. Schwartz (Author), Michael Szarek (Author), Ph. Gabriel Steg (Author), Sergio Fazio (Author)
• Format: Book
• Published: Elsevier, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Patients with recent acute coronary syndrome (ACS) commonly experience chest pain, which affects quality of life even when not due to recurrence of ACS. This post hoc analysis of ODYSSEY OUTCOMES assessed the effect of alirocumab, a proprotein convertase subtilisin/kexin type 9 inhibitor...